TNF and autoimmune disease: Our findings extended previous observations that TNF-α inhibitor benefits patients with autoimmune diseases (41–44) and the therapeutic efficacy of TNF-α inhibitor is better than traditional corticosteroids for patients with immune-related colitis (45, 46).